If not, you can flip the stock at any time for a profit. Investors have seriously recognized biotechnology as a distinct market sector since 1993. The Biotechnology Innovation Organization (BIO ...

Argus has a "buy" rating and $400 price target for UTHR stock, which closed at $362.33 on Jan. 7. Bio-Techne develops, manufactures and sells biotechnology reagents and instruments for the ...

Biotech is one of the U.S. stock market’s most unloved sectors. But several indicators suggest that a bottom in sentiment could be near, and that’s normally a good time to buy. Here are the ...

The improved sales of Nerlynx have been the primary reason for the stock’s increase in the past six months. Puma Biotechnology in-licensed the global development and commercialization rights to ...